S-Space

Browse

Title

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sort by
In order
Results/Page
Authors/record

Showing results 11,101 to 11,120 of 19,857

Issue Date	Title / Author(s) / Citation	File
2009-04	Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax Lim, Hyeong-Seok; Im, Jeong-Soo; Cho, Joo-Youn; Bae, Kyun-Seop; Yeom, Joon-Sup; Choi, Jae-Seon; Park, Jae-Won; Jang, In-Jin; Kim, Tae-Seon; Klein, Terry A. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Vol.53 4; 1468-1475	DOI
2010	Pharmacokinetics of Intravenous ceftazidime in Patients Undergoing Automated Peritoneal Dialysis and Correlation Between Intraperitoneal Pharmacokinetics and Peritoneal Membrane Transport Characterisitics 김기원	link
2009-08	Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line Hemodiafiltration Oh, Kook-Hwan; Kim, Chiweon; Lee, Hankyu; Lee, Hajeong; Kim, Nam Joong; Shin, Kwang-Hee; Ahn, Curie; Jang, In-Jin; Yu, Kyung-Sang; Jung, Ji Yong ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Vol.53 8; 3266-3268	DOI
2019-09	Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer Luo, Yang; Li, Wei; Jiang, Zefei; Zhang, Qingyuan; Wang, Liwei; Mao, Yixiang; Tjan-Heijnen, Vivianne C. G.; Im, Seock-Ah; McConnell, Robin; Bejarano, Sara; Fumagalli, Debora; Bines, Jose; Wang, Bei; Garg, Amit; Kirschbrown, Whitney P.; Xu, Binghe Anti-Cancer Drugs, Vol.30 No.8, pp.866-872	DOI
2008-11	Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study Lim, Kyoung Soo; Kim, Jung-Ryul; Choi, Yun-Jung; Shin, Kwang-Hee; Kim, Kyu-Pyo; Hong, Jang-Hee; Cho, Joo-Youn; Shin, Hyun-Suk; Yu, Kyung-Sang; Shin, Sang-Goo; Kwon, O Hwan; Hwang, Dal-Mi; Kim, Jeong-Ae; Jang, In-Jin Clin Ther. 2008;30(10):1817-1830	link
2021-11	Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid Tumors Takahashi, Shunji; Karayama, Masato; Takahashi, Masato; Watanabe, Junichiro; Minami, Hironobu; Yamamoto, Noboru; Kinoshita, Ichiro; Lin, Chia-Chi; Im, Young-Hyuck; Achiwa, Issei; Kamiyama, Emi; Okuda, Yasuyuki; Lee, Caleb; Bang, Yung-Jue Clinical Cancer Research, Vol.27 No.21, pp.5771-5780	DOI
2008-01	Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations Myrand, S P; Sekiguchi, K; Man, M Z; Lin, X; Tzeng, R-Y; Teng, C-H; Hee, B; Garrett, M; Kikkawa, H; Lin, C-Y; Eddy, S M; Dostalik, J; Mount, J; Azuma, J; Fujio, Y; Jang, I-J; Shin, S-G; Bleavins, M R; Williams, J A; Paulauskis, J D; Wilner, K D Clin Pharmacol Ther. 84(3), 347-361	link
2008-01	Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations Myrand, S. P.; Sekiguchi, K.; Man, M. Z.; Lin, X.; Tzeng, R. Y.; Teng, C. H.; Hee, B.; Garrett, M.; Kikkawa, H.; Lin, C. Y.; Eddy, S. M.; Dostalik, J.; Mount, J.; Azuma, J.; Fujio, Y.; Jang, I. J.; Shin, S. G.; Bleavins, M. R.; Williams, J. A.; Paulauskis, J. D.; Wilner, K. D. Clin Pharmacol Ther. 2008 Sep;84(3):347-61. Epub 2008 Mar 19.	link
2007-01	Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage Sinn, D. I.; Chu, K.; Lee, S. T.; Song, E. C.; Jung, K. H.; Kim, E. H.; Park, D. K.; Kang, K. M.; Kim, M.; Roh, J. K. Brain Res. 2007 Mar 2;1135(1):167-76. Epub 2006 Dec 15.	link
2007	Pharmacological induction of heat shock protein exerts neuroprotective effects in experimental intracerebral hemorrhage Sinn, Dong-In; Chu, Kon; Lee, Soon-Tae; Song, Eun-Cheol; Jung, Keun-Hwa; Kim, Eun-Hee; Park, Dong-Kyu; Kang, Kyung-Mook; Kim, Manho; Roh, Jae-Kyu Brain Res. 1135, 167-176	link
2006-11	Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation Chu, K.; Lee, S. T.; Sinn, D. I.; Ko, S. Y.; Kim, E. H.; Kim, J. M.; Kim, S. J.; Park, D. K.; Jung, K. H.; Song, E. C.; Lee, S. K.; Kim, M.; Roh, J. K. Stroke. 2007 Jan;38(1):177-82. Epub 2006 Nov 22.	view file link
2021-03	Pharmacological interventions for pulmonary involvement in rheumatic diseases Kang, Eun Ha; Song, Yeong Wook Pharmaceuticals, Vol.14 No.3, p. 251	DOI
2006	Phase 1 and 2 clinical studies of sustained-release praziquantel(SRP) for clonorchiasis 장병찬	link
2018-07	Phase 1 studies of poziotinib, an irreversible pan-her tyrosine kinase inhibitor in patients with advanced solid tumors Kim, Tae Min; Lee, Keun-Wook; Oh, Do-Youn; Lee, Jong-Seok; Im, Seock-Ah; Kim, Dong-Wan; Han, Sae-Won; Kim, Yu Jung; Kim, Tae-You; Kim, Jee Hyun; Han, Hyesun; Kim, Woo Ho; Bang, Yung-Jue Cancer Research and Treatment, Vol.50 No.3, pp.835-842	DOI
2020-02	Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue; Su, Wu-Chou; Schuler, Martin; Nam, Do-Hyun; Lim, Wan Teck; Bauer, Todd M.; Azaro, Analia; Poon, Ronnie Tung Ping; Hong, David; Lin, Chia-Chi; Akimov, Mikhail; Ghebremariam, Samson; Zhao, Sylvia; Giovannini, Monica; Ma, Brigette Cancer Science, Vol.111 No.2, pp.536-547	DOI
2015-08	Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma Keam, Bhumsuk; Kim, Sung-Bae; Shin, Seong Hoon; Cho, Byoung Chul; Lee, Keun-Wook; Kim, Min Kyoung; Yun, Hwan-Jung; Lee, Se-Hoon; Yoon, Dok Hyun; Bang, Yung-Jue Cancer, Vol.121 No.15, pp.2612-2617	DOI
2012-12	Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas Oh, Do-Youn; Kim, Tae-Won; Park, Young Suk; Shin, Sang Joon; Shin, Seong Hoon; Song, Eun-Kee; Lee, Hyo Jin; Lee, Kewn-Wook; Bang, Yung-Jue Cancer, Vol.118 No.24, pp.6162-6170	DOI
2018-04	Phase 2 study of the HSP-90 inhibitor AUY922 in previously treated and molecularly defined patients with advanced non-small cell lung cancer Felip, Enriqueta; Barlesi, Fabrice; Besse, Benjamin; Chu, Quincy; Gandhi, Leena; Kim, Sang-We; Carcereny, Enric; Sequist, Lecia V.; Brunsvig, Paal; Chouaid, Christos; Smit, Egbert F.; Groen, Harry J. M.; Kim, Dong-Wan; Park, Keunchil; Avsar, Emin; Szpakowski, Sebastian; Akimov, Mikhail; Garon, Edward B. Journal of Thoracic Oncology, Vol.13 No.4, pp.576-584	DOI
2004-06	Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Kim, Tae You; Kim, Dong-Wan; Chung, Jae-Yong; Shin, Sang Goo; Kim, Sung-Chul; Heo, Dae Seog; Kim, Noe Kyeong; Bang, Yung-Jue Clinical Cancer Research, Vol.10 No.11, pp.3708-3716	DOI
2022-09	Phase I Clinical Trial of Prostate-Specific Membrane Antigen-Targeting 68Ga-NGUL PET/CT in Healthy Volunteers and Patients with Prostate Cancer Suh, Minseok; Ryoo, Hyun Gee; Kang, Keon Wook; Jeong, Jae Min; Jeong, Chang Wook; Kwak, Cheol; Cheon, Gi Jeong Korean Journal of Radiology, Vol.23 No.9, pp.911-920	DOI

1 555 556 557 558 559 560 561 993